- likes
- 1,183
- comments
- 24
Post
The European Commission has approved an indication extension in the European Union for our Meningococcal Group A, C, W and Y conjugate vaccine to include use in infants from as young as 6 weeks of age to help protect against invasive meningococcal disease. Read our press release: http://spkl.io/60427z52s